<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Steinhoff MC</submitter><funding>Centers for Disease Control and Prevention</funding><funding>NIAID NIH HHS</funding><funding>Bill and Melinda Gates Foundation</funding><pagination>981-989</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5573632</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Influenza immunisation during pregnancy is recommended but not widely implemented in some low-income regions. We assessed the safety and efficacy in mothers and infants of year-round maternal influenza immunisation in Nepal, where influenza viruses circulate throughout the year.&lt;h4>Methods&lt;/h4>In this phase 4, randomised, placebo-controlled trial, we enrolled two consecutive sequential annual cohorts of pregnant women from the Sarlahi district in southern Nepal. We randomised mothers 1:1 to receive seasonally recommended trivalent inactivated influenza vaccine or saline placebo in blocks of eight, stratified by gestational age at enrolment (17-25 weeks vs 26-34 weeks). Women were eligible if they were married, 15-40 years of age, 17-34 weeks' gestation at enrolment, and </pubmed_abstract><journal>The Lancet. Infectious diseases</journal><pubmed_title>Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.</pubmed_title><pmcid>PMC5573632</pmcid><funding_grant_id>L30 AI107833</funding_grant_id><funding_grant_id>50274</funding_grant_id><funding_grant_id>K23 AI103105</funding_grant_id><pubmed_authors>Steinhoff MC</pubmed_authors><pubmed_authors>Chu HY</pubmed_authors><pubmed_authors>Reedy AM</pubmed_authors><pubmed_authors>Kuypers J</pubmed_authors><pubmed_authors>Tielsch JM</pubmed_authors><pubmed_authors>Shrestha L</pubmed_authors><pubmed_authors>Englund JA</pubmed_authors><pubmed_authors>Katz J</pubmed_authors><pubmed_authors>Khatry SK</pubmed_authors><pubmed_authors>Kozuki N</pubmed_authors><pubmed_authors>Stewart L</pubmed_authors><pubmed_authors>Mullany LC</pubmed_authors><pubmed_authors>LeClerq SC</pubmed_authors><pubmed_authors>McNeal M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.</name><description>&lt;h4>Background&lt;/h4>Influenza immunisation during pregnancy is recommended but not widely implemented in some low-income regions. We assessed the safety and efficacy in mothers and infants of year-round maternal influenza immunisation in Nepal, where influenza viruses circulate throughout the year.&lt;h4>Methods&lt;/h4>In this phase 4, randomised, placebo-controlled trial, we enrolled two consecutive sequential annual cohorts of pregnant women from the Sarlahi district in southern Nepal. We randomised mothers 1:1 to receive seasonally recommended trivalent inactivated influenza vaccine or saline placebo in blocks of eight, stratified by gestational age at enrolment (17-25 weeks vs 26-34 weeks). Women were eligible if they were married, 15-40 years of age, 17-34 weeks' gestation at enrolment, and </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2026-05-04T15:16:46.389Z</modification><creation>2019-03-26T23:53:49Z</creation></dates><accession>S-EPMC5573632</accession><cross_references><pubmed>28522338</pubmed><doi>10.1016/S1473-3099(17)30252-9</doi><doi>10.1016/s1473-3099(17)30252-9</doi></cross_references></HashMap>